J Hematol Mult Myeloma | Volume 2, Issue 1 | Case Report | Open Access

Acquired Hemophilia A as Early Manifestation of Multiple Myeloma: A Case Report

Mariasanta Napolitano^*, Simona Raso, Maria Rosa Lanza Cariccio, Melania Carlisi, Salvatrice Mancuso, Maria Grazia Lipari and Sergio Siragusa

Department of Internal Medicine and Specialties, Division of Haematology, University of Palermo, Palermo, Italy

^*Correspondance to: Mariasanta Napolitano 

Fulltext PDF

Abstract

Acquired Hemophilia A is a rare bleeding disorder and commonly associated with issues during pregnancy and postpartum status, autoimmune disorders, malignancies, dermatological conditions, infections or drug interactions. AHA treatment depends on the site and severity of the bleed and immunosuppressive agents administered. We report a case with overt multiple myeloma (MM) five year after AHA onset, with a long-lasting response to factor FVIII autoantibodies after specific treatment for the underlying Multiple Myeloma. During the last follow-up treatment, the patient had undetectable M component and normal coagulation parameters.

Citation:

Napolitano M, Raso S, Cariccio MRL,Carlisi M, Mancuso S, Lipari MG, et al. Acquired Hemophilia A as Early Manifestation of Multiple Myeloma: A Case Report. J Hematol Mult Myeloma. 2017;2(1):1006.